NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Cost of Revenue in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Cost of Revenue history and growth rate from Q4 2020 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the quarter ending September 30, 2024 was $131K, a 76.1% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the twelve months ending September 30, 2024 was $2.37M, a 58.7% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2024 was $2.37M, a 58.7% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2023 was $1.5M, a 518% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2022 was $242K, a 12.3% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.37M $131K -$417K -76.1% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 $2.79M $544K +$158K +40.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.63M $987K +$552K +127% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.08M $711K +$584K +461% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $1.5M $548K +$464K +554% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 $1.03M $386K +$348K +904% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $684K $435K +$362K +497% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $322K $127K +$80K +171% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $242K $83.9K +$18.4K +28.1% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 $224K $38.5K -$23.5K -37.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $247K $72.8K +$33.4K +85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $214K $46.8K -$62.3K -57.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $276K $65.5K Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 $61.9K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $39.4K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $109K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.